![](/images/products/large/703044.jpg)
Coping with a Difficult Compliance Officer when Responding to a 483, Warning Letter, Import Alert or Recall
Marc Sanchez
60 Min
Product Id: 703044
This webinar on handling FDA inspectors will discuss practical tips to cope with a difficult FDA compliance officer or inspector. You will learn how to wiggle out of complicated situations, make legal arguments and challenges to the FDA agent and use meeting requests and other tools to ease tensions.
![](/images/products/large/702548.jpg)
3-hr Virtual Seminar - China: Compliance Processes for Life Science Products (Company Establishment, Clinical Trials, Registrations, Renewals and Supply Chain Considerations)
Robert J Russell
3 hrs
Product Id: 702548
This 3 hour virtual seminar on China regulatory compliance processes for life science products will discuss the regulatory structure and requirements for compliance against China’s CFDA regulations for Pharmaceuticals, Medical Devices, Biologics and Combination Products.
![](/images/products/large/703004.jpg)
Essential Last Minute Preparation for an Imminent FDA Inspection
Chris Cook
60 Min
Product Id: 703004
This webinar on preparing for FDA inspections will present simple but powerful tools, with real world examples on how to prepare for an impending FDA inspection. You will learn what essential last minute preparation activities can be done and others that should be avoided.
![](/images/products/large/702998.jpg)
Additional Medicare Reporting Under the Sunshine Act Rules of 2013
Mukesh Kumar
60 Min
Product Id: 702998
This webinar will provide a summary of the additional medicare reporting requirements under the Sunshine Act rules, and tips for assuring compliance to protect both the manufacturers of FDA regulated products and physicians.
![](/images/products/large/702907.jpg)
FDA and Social Media - How to Promote your Products Using Web 2.0 in Compliance with FDA and FTC Laws and Regulations
Mark Gardner
90 Min
Product Id: 702907
This webinar on FDA social media regulations will discuss the best practices utilized by medical device, drug and other FDA and FTC regulated industries when using social media channels, i.e., Web 2.0, like Facebook, Twitter, YouTube and LinkedIn to promote products.
![](/images/products/large/701551.jpg)
Immunogenicity To Biologics: Processes, Impact On Efficacy And Safety, and Management Strategy
Chitra Edwin
60 Min
Product Id: 701551
This training will discuss the processes and effects of immunogenicity to biologics and the screening methodologies to measure immune response. Participants will learn how to apply regulatory mandates and about the commercial repercussions of unwanted immune responses.
![](/images/products/large/702825.jpg)
The Sunshine Act Final Rule
Mark Gardner
120 Min
Product Id: 702825
This session will discuss in detail the Final Rule for the Physician Payment Sunshine Act, its impact and how to prepare for it. You will learn about reporting, certification and registration deadlines and what specifically needs to be reported or provided to CMS.
![](/images/products/large/702808.jpg)
How to Make GMP Training Fun and Engaging
Grimoalda Botelho
60 Min
Product Id: 702808
This session on conducting effective GMP trainings will cover proven learning techniques for technical and compliance related trainings. It will answer key questions about how to make GMP training sessions more engaging and even fun for the learners in your organization.
![](/images/products/large/702797.jpg)
FDA Warning Letters - Stop Fumbling your Response and Effectively Demonstrate Compliance
Marc Sanchez
60 Min
Product Id: 702797
This training will outline the best practices in responding to a FDA Warning Letter so the consequences of the findings do not escalate beyond the current status.
![](/images/products/large/702693.jpg)
The Role of Social Media in Food and Drug Advertising and Regulatory Compliance Implications
Bradley Johnson
60 Min
Product Id: 702693
This webinar on social media advertising compliance will provide perspective on how food and drug companies can leverage social media to promote brands, discuss how social media can expose companies to unique regulatory compliance challenges, and show how company compliance programs can be designed to address these challenges.
![](/images/products/large/702739.jpg)
The Caronia Court Decision and Off-Label Promotion: What Does this Mean for FDA's Regulation of Pharmaceutical and Medical Device Off-Label Marketing and Promotion?
Karl M. Nobert
90 Min
Product Id: 702739
This webinar will provide an introduction to FDA’s regulation of product labeling and promotion; and the Agency’s position with regards to off-label promotion and how the Court’s decision in the Caronia case might affect the off-label promotion of Rx drug products and medical devices.
![](/images/products/large/702481.jpg)
Introduction to Biotechnology Analytical Methods
Robert D Seltzer
75 Min
Product Id: 702481
This webinar will highlight the evidence normally requested during audits and inspections of biotechnology analytical labs. You will learn how your laboratory's biotechnology analytical methods can fulfill stated or implied regulatory requirements (the US FDA refers to these as the “C” in CGMPs).
![](/images/products/large/702672.jpg)
Using Electronic and Digital Signatures in Regulated Environments
Dr. Ludwig Huber
75 Min
Product Id: 702672
This webinar will familiarize you with FDA requirements for electronic and digital signatures, and the agency's inspection and enforcement practices. Particpants will recieve complimentary hand-outs for easy implementation.
![](/images/products/large/702614.jpg)
Product Complaint Investigations - The application of Lean Six Sigma methodology for U.S. FDA-Regulated Industries
Shahbaz Shahbazi,Ray Bandziulis
75 Min
Product Id: 702614
This webinar will discuss the use of Lean Six Sigma methodology for product complaint investigations and offer a standardized approach for FDA regulated life science companies to follow whenever product complaint investigations are needed.
![](/images/products/large/702446.jpg)
Personnel Practices and Microbial Control in Pharmaceutical, Biotech, and Medical Device Manufacturing
Jim Polarine
90 Min
Product Id: 702446
This 90-minute webinar on personnel practices and microbial control in Pharmaceutical, Biotech, and Medical Device manufacturing will cover effective ways to train personnel on gowning and personnel practices in cleanroom operations to limit contamination. This webinar will also address controlling microorganisms on process equipment and product contact surfaces.
![](/images/products/large/702486.jpg)
Freeze Drying in the Pharmaceutical, Biological and Food industry
J. Jeff Schwegman
90 Min
Product Id: 702486
This 90-minute session will cover the basics of freeze drying as it relates to the pharmaceutical, biological and food industries. Specifically, this session will highlight using a scientific approach to developing an optimal formulation and lyophilization cycle for those freeze-drying in these industries.
![](/images/products/large/702314.jpg)
Eliminate the Confusion - Analytical Method Qualification and Validation
Melissa Smith
60 Min
Product Id: 702314
This webinar will help you understand the significant differences between qualification and validation of an analytical method, the expectations and requirements of each, and their place in the analytical method lifecycle.
![](/images/products/large/702396.jpg)
Biomarkers for Drug Development: The Emerging Regulatory Landscape
Orest Hurko
60 Min
Product Id: 702396
This training provides an up-to-date understanding of regulatory requirements for the development and implementation of biomarkers in drug development programs, as well as highlights of the most recent FDA sources on general, imaging (Including PET) and pharmacogenomic biomarkers.
![](/images/products/large/702325.jpg)
Making Sense of FDA's (proposed) Rules for the Development and Approval of Biosimilars
Karl M. Nobert
60 Min
Product Id: 702325
This webinar will help you understand the process, requirements, quality and safety considerations for demonstrating biosimilarity to a Reference Product. You will learn about what type and how much clinical data are needed to support a showing of biosimilarity.
![](/images/products/large/702322.jpg)
FDA's Regulation of Veterinary Regenerative Medicine: What Industry Needs to Know to Market and Sell a Stem Cell Product for Use in Dogs, Cats, Horses and other Animals
Karl M. Nobert
60 Min
Product Id: 702322
This webinar will provide an introduction to FDA’s regulation of veterinary regenerative medicine and highlight the regulatory requirements that a biotech company needs to satisfy to commercialize a stem cell or other complex biotech product for animal use in the U.S.